Total Payments
$3,712
2024 Payments
$133.26
Companies
17
Transactions
108
Payment Breakdown by Category
Food & Beverage$3,712 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,712 | 108 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,287 | 13 | $0 (2020) |
| Allergan, Inc. | $922.70 | 40 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $425.97 | 8 | $0 (2022) |
| Alkermes, Inc. | $223.80 | 3 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $137.49 | 5 | $0 (2018) |
| Shire North American Group Inc | $118.48 | 6 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $118.08 | 3 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $114.94 | 10 | $0 (2019) |
| ABBVIE INC. | $95.47 | 4 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $80.56 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $133.26 | 2 | Alkermes, Inc. ($112.65) |
| 2023 | $58.49 | 2 | ABBVIE INC. ($58.49) |
| 2022 | $211.75 | 2 | Otsuka America Pharmaceutical, Inc. ($123.79) |
| 2021 | $101.08 | 2 | Janssen Pharmaceuticals, Inc ($84.71) |
| 2020 | $256.99 | 8 | Otsuka America Pharmaceutical, Inc. ($117.32) |
| 2019 | $1,312 | 46 | Sunovion Pharmaceuticals Inc. ($615.45) |
| 2018 | $921.20 | 22 | Sunovion Pharmaceuticals Inc. ($439.44) |
| 2017 | $716.90 | 24 | Sunovion Pharmaceuticals Inc. ($212.67) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $112.65 | General |
| Category: CNS | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $87.96 | General |
| Category: CNS | ||||||
| 03/30/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $123.79 | General |
| Category: PSYCHIATRY | ||||||
| 09/22/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $84.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/22/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $117.32 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 01/29/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: NEUROSCIENCE | ||||||
| 01/15/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: CNS | ||||||
| 12/18/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: CNS | ||||||
| 12/06/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $121.54 | General |
| Category: CNS | ||||||
| 11/14/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Larry Momaya, MD
Dr. Larry Momaya, MD is a Psychiatry healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962572263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Larry Momaya, MD has received a total of $3,712 in payments from pharmaceutical and medical device companies, with $133.26 received in 2024. These payments were reported across 108 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,712).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Newport Beach, CA
- Active Since 11/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1962572263
Products in Payments
- LATUDA (Drug) $1,287
- VRAYLAR (Drug) $1,018
- REXULTI (Drug) $308.65
- LYBALVI (Drug) $200.61
- Trintellix (Drug) $145.88
- BELSOMRA (Drug) $137.49
- ABILIFY MAINTENA (Drug) $117.32
- MYDAYIS (Drug) $100.40
- XARELTO (Drug) $84.71
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $80.56
- SPRAVATO (Drug) $33.37
- Fanapt (Drug) $32.14
- NUPLAZID (Drug) $25.42
- Vivitrol 380 mg (Drug) $23.19
- Vyvanse (Drug) $23.06
- TRINTELLIX (Drug) $21.31
- APLENZIN (Drug) $18.74
- ADHANSIA XR (Drug) $18.67
- VYVANSE (Drug) $18.08
- NUEDEXTA (Drug) $16.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Newport Beach
Dr. Nader Oskooilar, Md, MD
Psychiatry — Payments: $321,179
Psychiatry $321,179
Dr. Hadi Estakhri, M.d, M.D
Psychiatry — Payments: $16,721
Psychiatry $16,721
Dr. Venice Sanchez, M.d, M.D
Psychiatry — Payments: $16,294
Psychiatry $16,294
Dr. Hisham Korraa, M.d, M.D
Psychiatry — Payments: $14,252
Psychiatry $14,252
Dr. Stefani Lafrenierre, Md, MD
Psychiatry — Payments: $7,842
Psychiatry $7,842
Nimisha Jain, Pa, PA
Psychiatry — Payments: $6,289
Psychiatry $6,289